检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:林毅[1] 王振飞[1] 王智健[1] 甘平 LIN Yi;WANG Zhenfei;WANG Zhijian;GAN Ping(Area Three of Proctology, the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fujian Province, Fuzhou 350004, Chin)
机构地区:[1]福建中医药大学附属人民医院肛肠科三区,福州350004
出 处:《中国中医药现代远程教育》2017年第22期107-109,共3页Chinese Medicine Modern Distance Education of China
摘 要:目的探讨华蟾素片联合XELOX方案对于结直肠癌术后化疗的临床价值。方法根据纳入标准,收集2014—2016年收治的80例结直肠癌术后患者的临床资料。按照随机法均分为试验组和对照组,分别给予华蟾素片联合XELOX方案和单纯XELOX方案,比较2组的临床疗效。结果试验组患者化疗后的生活质量的改善方面明显优于对照组;并且试验组在白细胞下降、减少恶心呕吐等毒副作用方面明显优于对照组;2组患者治疗前后癌胚抗原(CEA)水平经比较均有显著下降,且试验组的下降更加显著,差异有统计学意义(P<0.05)。结论华蟾素片联合XELOX方案能够明显提高患者的生活质量,有效提高化疗效果,减轻化疗的毒副反应发生率,临床效果显著。Objective To discuss the clinical value of Cinobufotalin combined with XELOX regimen in chemotherapy after colorectal cancer surgery. Methods From 2014 to 2016, according to the inclusion index, a total of 80 patients after colorectal cancer surgery were randomly divided into the observation group and the control group, with 40 cases in each group. The control group received XELOX regimen. Moreover, the observation group received Cinobufotalin combined with XELOX regimen. The clinical effect of the two groups was compared. Results The improvement in quality of life of the observation group was obviously better than that of the control group. Meanwhile, in terms of Leucopenia, nausea and vomiting, the observation group was better than the control group. The laboratory tests of CEA after the treatment, the both groups had obvious reduction, and the observation group had a significant reduction in statistics( P 0.05). Conclusion Cinobufotalin combined with XELOX regimen had significant clinical effect, which reflected in improving the life quality, enhancing the chemotherapy effect, and reducing chemotherapy response.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.147